Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5NCY

mPI3Kd IN COMPLEX WITH inh1

Summary for 5NCY
Entry DOI10.2210/pdb5ncy/pdb
DescriptorPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform, 1,2-ETHANEDIOL, SULFATE ION, ... (5 entities in total)
Functional Keywordsmi3kd, inhibitor, complex pi3k, transferase
Biological sourceMus musculus (Mouse)
Cellular locationCytoplasm : O35904
Total number of polymer chains1
Total formula weight108364.29
Authors
Petersen, J. (deposition date: 2017-03-06, release date: 2017-06-21, Last modification date: 2024-05-01)
Primary citationPerry, M.W.D.,Bjorhall, K.,Bonn, B.,Carlsson, J.,Chen, Y.,Eriksson, A.,Fredlund, L.,Hao, H.,Holden, N.S.,Karabelas, K.,Lindmark, H.,Liu, F.,Pemberton, N.,Petersen, J.,Rodrigo Blomqvist, S.,Smith, R.W.,Svensson, T.,Terstiege, I.,Tyrchan, C.,Yang, W.,Zhao, S.,Oster, L.
Design and Synthesis of Soluble and Cell-Permeable PI3K delta Inhibitors for Long-Acting Inhaled Administration.
J. Med. Chem., 60:5057-5071, 2017
Cited by
PubMed Abstract: PI3Kδ is a lipid kinase that is believed to be important in the migration and activation of cells of the immune system. Inhibition is hypothesized to provide a powerful yet selective immunomodulatory effect that may be beneficial for the treatment of conditions such as asthma or rheumatoid arthritis. In this work, we describe the identification of inhibitors based on a thiazolopyridone core structure and their subsequent optimization for inhalation. The initially identified compound (13) had good potency and isoform selectivity but was not suitable for inhalation. Addition of basic substituents to a region of the molecule pointing to solvent was tolerated (enzyme inhibition pIC > 9), and by careful manipulation of the pK and lipophilicity, we were able to discover compounds (20b, 20f) with good lung retention and cell potency that could be taken forward to in vivo studies where significant target engagement could be demonstrated.
PubMed: 28520415
DOI: 10.1021/acs.jmedchem.7b00401
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

236620

PDB entries from 2025-05-28

PDB statisticsPDBj update infoContact PDBjnumon